Sepsis-Induced Coagulopathy Score is Associated with an Increased Risk of New-Onset Atrial Fibrillation in Septic Patients: A Two-Centered Retrospective Study

被引:0
|
作者
Li, Juan [1 ]
Wang, Shu [2 ]
Ma, Chaoping [1 ]
Ning, Ning [3 ]
Huang, Yingying [1 ,4 ]
Jiao, Min [1 ]
Zhang, Jiyuan [1 ]
Sun, Wenwu [3 ]
Li, Jiaoyan [3 ]
Zhao, Bing [3 ]
Mao, Enqiang [3 ]
Che, Zaiqian [3 ]
Gao, Chengjin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Emergency, 1665 Kongjiang Rd, Shanghai 200025, Peoples R China
[2] Chongqing Univ, Cent Hosp, Chongqing Emergency Med Ctr, Dept Intens Care Med, Chongqing 400016, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Emergency, Shanghai 200025, Peoples R China
[4] Macquarie Univ, Dementia Res Ctr, Sydney, Australia
基金
中国国家自然科学基金;
关键词
sepsis; sepsis-induced coagulopathy; new-onset atrial fibrillation; association; mortality; COAGULATION; STROKE;
D O I
10.2147/JIR.S467424
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: New-onset atrial fibrillation (NOAF) and sepsis-induced coagulopathy (SIC) are severe complications in septic patients. However, the relationship between NOAF and SIC score has not been clearly defined. This study aims to investigate the association between SIC score and NOAF, as well as their effect on mortality in sepsis. Patients and Methods: This study was a two-center retrospective analysis. Medical data were collected from patients diagnosed with sepsis. The patients were divided into NOAF and non-NOAF groups, and the SIC score was calculated for each group. Univariable and multivariable logistic regression analyses were performed to explore the relationship between the SIC score and NOAF, as well as their effects on mortality. The Kaplan-Meier curve was used to assess the survival rate. Results: A total of 2,280 septic patients were included, with 132 (5.7%) suffering from NOAF. Multivariable logistic regression analyses indicated that age, gender, the Acute Physiology and Chronic Health Evaluation II score (APACHE II), heart rate, renal failure, stroke, chronic obstructive pulmonary disease (COPD), and the SIC score were independent risk factors for NOAF in sepsis. Moreover, NOAF was associated with an increased risk of in-hospital mortality, 28-day mortality, and 90-day mortality. These results were consistent across subgroup analyses. Conclusion: The SIC score was an independent risk factor for NOAF in septic patients, and NOAF was an independent risk factor for predicting mortality.
引用
收藏
页码:5889 / 5899
页数:11
相关论文
共 50 条
  • [21] Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan
    Tanaka, Chie
    Tagami, Takashi
    Kudo, Saori
    Takehara, Akiko
    Fukuda, Reo
    Nakayama, Fumihiko
    Kaneko, Junya
    Ishiki, Yoshito
    Sato, Shin
    Kuno, Masamune
    Unemoto, Kyoko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (02) : 164 - 171
  • [22] Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan
    Chie Tanaka
    Takashi Tagami
    Saori Kudo
    Akiko Takehara
    Reo Fukuda
    Fumihiko Nakayama
    Junya Kaneko
    Yoshito Ishiki
    Shin Sato
    Masamune Kuno
    Kyoko Unemoto
    International Journal of Hematology, 2021, 114 : 164 - 171
  • [23] Impending sepsis-induced coagulopathy (SIC) is associated with increased disease severity in SIC-negative patients: a secondary analysis of a prospective exploratory study
    Schmoch, Thomas
    Moehnle, Patrick
    Nusshag, Christian
    Feisst, Manuel
    Weigand, Markus A.
    Brenner, Thorsten
    FRONTIERS IN MEDICINE, 2025, 12
  • [24] Adverse Outcomes Associated with Pre-Existing and New-Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome: A Retrospective Cohort Study
    Chun-Li Wang
    Pei-Chun Chen
    Hsiao-Ting Juang
    Chee-Jen Chang
    Cardiology and Therapy, 2019, 8 : 117 - 127
  • [25] Adverse Outcomes Associated with Pre-Existing and New-Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome: A Retrospective Cohort Study
    Wang, Chun-Li
    Chen, Pei-Chun
    Juang, Hsiao-Ting
    Chang, Chee-Jen
    CARDIOLOGY AND THERAPY, 2019, 8 (01) : 117 - 127
  • [26] New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study
    Fernando, Shannon M.
    Mathew, Rebecca
    Hibbert, Benjamin
    Rochwerg, Bram
    Munshi, Laveena
    Walkey, Allan J.
    Moller, Morten Hylander
    Simard, Trevor
    Di Santo, Pietro
    Ramirez, F. Daniel
    Tanuseputro, Peter
    Kyeremanteng, Kwadwo
    CRITICAL CARE, 2020, 24 (01)
  • [27] New-onset atrial fibrillation is associated with increased mortality in critically ill patients: a systematic review and meta-analysis
    Kanjanahattakij, Napatt
    Rattanawong, Pattara
    Krishnamoorthy, Parasuram
    Horn, Benjamin
    Chongsathidkiet, Pakawat
    Garvia, Veronica
    Putthapiban, Prapaipan
    Sirinvaravong, Natee
    Figueredo, Vincent M.
    ACTA CARDIOLOGICA, 2019, 74 (02) : 162 - 169
  • [28] Serum fibrinogen-to-albumin ratio predicts new-onset atrial fibrillation risk during hospitalization in patients with acute myocardial infarction after percutaneous coronary intervention: a retrospective study
    Bao, Jiaqi
    Gao, Zhicheng
    Hu, Yilan
    Liu, Wenquan
    Ye, Lifang
    Wang, Lihong
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [29] Risk factors and outcomes of new-onset atrial fibrillation in patients hospitalized in an internal medicine ward: a case-control study
    Para, Ombretta
    Caruso, Lorenzo
    Corbo, Lorenzo
    Bacci, Francesca
    Pasqui, Niccolo
    Pieralli, Filippo
    Ciarambino, Tiziana
    Nozzoli, Carlo
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (02) : 251 - 256
  • [30] Amlexanox reduces new-onset atrial fibrillation risk in sepsis by downregulating S100A12: a Mendelian randomization study
    Yang, Hang
    Feng, Lin
    Jiang, Zhenjie
    Wu, Xiaodan
    Zeng, Kai
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11